Interleukin-6 (IL-6), a 26 kDa, alpha-helical protein, is produced locally in the nervous system by astrocytes, microglia, and neurons, and is important in activating infiltrating macrophages, regulating B cell growth and differentiation as well as inducing T cell responses (Frei
暂无分享,去创建一个
[1] S. Levison,et al. Ciliary neurotrophic factor and interleukin‐6 differentially activate microglia , 2008, Journal of neuroscience research.
[2] J. Scheller,et al. Interleukin‐6 biology is coordinated by membrane‐bound and soluble receptors: role in inflammation and cancer , 2006, Journal of leukocyte biology.
[3] P. Patterson,et al. Potent pro-inflammatory actions of leukemia inhibitory factor in the spinal cord of the adult mouse , 2004, Experimental Neurology.
[4] M. Michalopoulou,et al. Soluble interleukin-6 receptor (sIL-6R) in cerebrospinal fluid of patients with inflammatory and non inflammatory neurological diseases. , 2004, Immunology letters.
[5] Guang-Xian Zhang,et al. Role of the IL-12/IL-23 system in the regulation of T-cell responses in central nervous system inflammatory demyelination. , 2004, Critical reviews in immunology.
[6] Jonathan R. Enterline,et al. Astrocytes produce CNTF during the remyelination phase of viral-induced spinal cord demyelination to stimulate FGF-2 production , 2003, Neurobiology of Disease.
[7] T. Chaiworapongsa,et al. Intrauterine infection and the development of cerebral palsy. , 2003 .
[8] D. Wesemann,et al. Suppressor of Cytokine Signaling 1 Inhibits Cytokine Induction of CD40 Expression in Macrophages1 , 2002, The Journal of Immunology.
[9] P. Ricciardi-Castagnoli,et al. Granulocyte-Macrophage Colony-Stimulating Factor Induces an Expression Program in Neonatal Microglia That Primes Them for Antigen Presentation1 , 2002, The Journal of Immunology.
[10] D. Barford,et al. TYK2 and JAK2 Are Substrates of Protein-tyrosine Phosphatase 1B* , 2001, The Journal of Biological Chemistry.
[11] Andrew L. Kung,et al. Role of T-bet in Commitment of TH1 Cells Before IL-12-Dependent Selection , 2001, Science.
[12] Josef M. Penninger,et al. CD45 is a JAK phosphatase and negatively regulates cytokine receptor signalling , 2001, Nature.
[13] N. Tanuma,et al. Protein-tyrosine phosphatase PTPepsilon C inhibits Jak-STAT signaling and differentiation induced by interleukin-6 and leukemia inhibitory factor in M1 leukemia cells. , 2000, The Journal of biological chemistry.
[14] V. Nguyen,et al. Involvement of STAT-1 and Ets Family Members in Interferon-γ Induction of CD40 Transcription in Microglia/Macrophages* , 2000, The Journal of Biological Chemistry.
[15] P. Igaz,et al. Soluble interleukin-6 receptor (sIL-6R) makes IL-6R negative T cell line respond to IL-6; it inhibits TNF production. , 2000, Immunology letters.
[16] S. Tóth,et al. Generation of 'truncated' interleukin-6 receptor (IL-6R) mRNA by alternative splicing; a possible source of soluble IL-6R. , 1999, Immunology letters.
[17] H. Bluethmann,et al. Strongly compromised inflammatory response to brain injury in interleukin‐6‐deficient mice , 1999, Glia.
[18] B. Hilliard,et al. IL-6-deficient mice are resistant to experimental autoimmune encephalomyelitis: roles of IL-6 in the activation and differentiation of autoreactive T cells. , 1998, Journal of immunology.
[19] I. Kerr,et al. Activation of the protein tyrosine phosphatase SHP2 via the interleukin-6 signal transducing receptor protein gp130 requires tyrosine kinase Jak1 and limits acute-phase protein expression. , 1998, The Biochemical journal.
[20] K. Frei,et al. IL‐6‐deficient mice resist myelin oligodendrocyte glycoprotein‐induced autoimmune encephalomyelitis , 1998, European journal of immunology.
[21] H. Baumann,et al. Protein Tyrosine Phosphatase 2 (SHP-2) Moderates Signaling by gp130 but Is Not Required for the Induction of Acute-Phase Plasma Protein Genes in Hepatic Cells , 1998, Molecular and Cellular Biology.
[22] P. Patterson,et al. Leukemia Inhibitory Factor Is Expressed in Astrocytes Following Cortical Brain Injury , 1997, Experimental Neurology.
[23] L. Adorini,et al. IL-12 production by central nervous system microglia is inhibited by astrocytes. , 1997, Journal of immunology.
[24] J. Chi,et al. High expression of tumor necrosis factor-α and interleukin-6 in periventricular leukomalacia ☆ ☆☆ ★ ★★ ♢ , 1997 .
[25] G. Guazzi,et al. IL-6 detection in multiple sclerosis brain , 1997, Journal of the Neurological Sciences.
[26] S. Rose-John,et al. The function of the soluble IL-6 receptor in vivo. , 1996, Immunology letters.
[27] J. Antel,et al. Soluble tumor necrosis factor receptor inhibits interleukin 12 production by stimulated human adult microglial cells in vitro. , 1996, The Journal of clinical investigation.
[28] H. Link,et al. Shift from anti- to proinflammatory cytokine profiles in microglia through LPS- or IFN-gamma-mediated pathways. , 1996, Neuroreport.
[29] R. Romero,et al. Interleukin-6 concentrations in umbilical cord plasma are elevated in neonates with white matter lesions associated with periventricular leukomalacia. , 1996, American journal of obstetrics and gynecology.
[30] P. Kivisäkk,et al. Increased interleukin-6 mRNA expression in blood and cerebrospinal fluid mononuclear cells in multiple sclerosis , 1996, Journal of Neuroimmunology.
[31] Peter Riederer,et al. Interleukin-1β and interleukin-6 are elevated in the cerebrospinal fluid of Alzheimer's and de novo Parkinson's disease patients , 1995, Neuroscience Letters.
[32] P. Heinrich,et al. The soluble human IL-6 receptor. Mutational characterization of the proteolytic cleavage site. , 1994, Journal of immunology.
[33] G. Yancopoulos,et al. Association and activation of Jak-Tyk kinases by CNTF-LIF-OSM-IL-6 beta receptor components. , 1994, Science.
[34] A. Stalder,et al. Reactive gliosis as a consequence of interleukin-6 expression in the brain: studies in transgenic mice. , 1994, Developmental neuroscience.
[35] L. Mucke,et al. Neurologic disease induced in transgenic mice by cerebral overexpression of interleukin 6. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[36] J. R. Unnerstall,et al. The expression of CNTF message and immunoreactivity in the central and peripheral nervous system of the rat. , 1992, Brain research. Developmental brain research.
[37] H. Thoenen,et al. Regional distribution, developmental changes, and cellular localization of CNTF-mRNA and protein in the rat brain , 1991, The Journal of cell biology.
[38] U. Schreiter-Gasser,et al. Interleukin‐6 and α‐2‐macroglobulin indicate an acute‐phase state in Alzheimer's disease cortices , 1991, FEBS letters.
[39] W. Fiers,et al. Is amyloidogenesis during Alzheimer's disease due to an IL-1-/IL-6-mediated 'acute phase response' in the brain? , 1991, Immunology today.
[40] A. Reder,et al. Cytokine levels in the cerebrospinal fluid and serum of patients with multiple sclerosis , 1991, Journal of Neuroimmunology.
[41] A. Fontana,et al. Interleukin-6 is elevated in plasma in multiple sclerosis , 1991, Journal of Neuroimmunology.
[42] R. Zinkernagel,et al. On the cellular source and function of interleukin 6 produced in the central nervous system in viral diseases , 1989, European journal of immunology.
[43] S. Levison,et al. Ciliary neurotrophic factor and interleukin‐6 differentially activate microglia , 2008, Journal of neuroscience research.
[44] J. Scheller,et al. Interleukin‐6 biology is coordinated by membrane‐bound and soluble receptors: role in inflammation and cancer , 2006, Journal of leukocyte biology.
[45] P. Patterson,et al. Potent pro-inflammatory actions of leukemia inhibitory factor in the spinal cord of the adult mouse , 2004, Experimental Neurology.
[46] M. Michalopoulou,et al. Soluble interleukin-6 receptor (sIL-6R) in cerebrospinal fluid of patients with inflammatory and non inflammatory neurological diseases. , 2004, Immunology letters.
[47] C. Gutiérrez,et al. High expression of tumor necrosis factor alpha receptors in peripheral blood mononuclear cells of obese type 2 diabetic women. , 2004, European cytokine network.
[48] Guang-Xian Zhang,et al. Role of the IL-12/IL-23 system in the regulation of T-cell responses in central nervous system inflammatory demyelination. , 2004, Critical reviews in immunology.
[49] Jonathan R. Enterline,et al. Astrocytes produce CNTF during the remyelination phase of viral-induced spinal cord demyelination to stimulate FGF-2 production , 2003, Neurobiology of Disease.
[50] T. Chaiworapongsa,et al. Intrauterine infection and the development of cerebral palsy , 2003, BJOG : an international journal of obstetrics and gynaecology.
[51] D. Wesemann,et al. This information is current as Macrophages Cytokine Induction of CD 40 Expression in Suppressor of Cytokine Signaling 1 Inhibits , 2002 .
[52] D. Barford,et al. TYK2 and JAK2 Are Substrates of Protein-tyrosine Phosphatase 1B* , 2001, The Journal of Biological Chemistry.
[53] Andrew L. Kung,et al. Role of T-bet in Commitment of TH1 Cells Before IL-12-Dependent Selection , 2001, Science.
[54] Josef M. Penninger,et al. CD45 is a JAK phosphatase and negatively regulates cytokine receptor signalling , 2001, Nature.
[55] N. Tanuma,et al. Protein-tyrosine phosphatase PTPepsilon C inhibits Jak-STAT signaling and differentiation induced by interleukin-6 and leukemia inhibitory factor in M1 leukemia cells. , 2000, The Journal of biological chemistry.
[56] V. Nguyen,et al. Involvement of STAT-1 and Ets Family Members in Interferon-γ Induction of CD40 Transcription in Microglia/Macrophages* , 2000, The Journal of Biological Chemistry.
[57] P. Igaz,et al. Soluble interleukin-6 receptor (sIL-6R) makes IL-6R negative T cell line respond to IL-6; it inhibits TNF production. , 2000, Immunology letters.
[58] S. Tóth,et al. Generation of 'truncated' interleukin-6 receptor (IL-6R) mRNA by alternative splicing; a possible source of soluble IL-6R. , 1999, Immunology letters.
[59] H. Bluethmann,et al. Strongly compromised inflammatory response to brain injury in interleukin‐6‐deficient mice , 1999, Glia.
[60] B. Hilliard,et al. IL-6-deficient mice are resistant to experimental autoimmune encephalomyelitis: roles of IL-6 in the activation and differentiation of autoreactive T cells. , 1998, Journal of immunology.
[61] I. Kerr,et al. Activation of the protein tyrosine phosphatase SHP2 via the interleukin-6 signal transducing receptor protein gp130 requires tyrosine kinase Jak1 and limits acute-phase protein expression. , 1998, The Biochemical journal.
[62] K. Frei,et al. IL‐6‐deficient mice resist myelin oligodendrocyte glycoprotein‐induced autoimmune encephalomyelitis , 1998, European journal of immunology.
[63] H. Baumann,et al. Protein Tyrosine Phosphatase 2 (SHP-2) Moderates Signaling by gp130 but Is Not Required for the Induction of Acute-Phase Plasma Protein Genes in Hepatic Cells , 1998, Molecular and Cellular Biology.
[64] P. Patterson,et al. Leukemia Inhibitory Factor Is Expressed in Astrocytes Following Cortical Brain Injury , 1997, Experimental Neurology.
[65] L. Adorini,et al. IL-12 production by central nervous system microglia is inhibited by astrocytes. , 1997, Journal of immunology.
[66] G. Guazzi,et al. IL-6 detection in multiple sclerosis brain , 1997, Journal of the Neurological Sciences.
[67] J. Chi,et al. High expression of tumor necrosis factor-alpha and interleukin-6 in periventricular leukomalacia. , 1997, American journal of obstetrics and gynecology.
[68] S. Rose-John,et al. The function of the soluble IL-6 receptor in vivo. , 1996, Immunology letters.
[69] R. Romero,et al. Interleukin-6 concentrations in umbilical cord plasma are elevated in neonates with white matter lesions associated with periventricular leukomalacia , 1996 .
[70] J. Antel,et al. Soluble tumor necrosis factor receptor inhibits interleukin 12 production by stimulated human adult microglial cells in vitro. , 1996, The Journal of clinical investigation.
[71] H. Link,et al. Shift from anti- to proinflammatory cytokine profiles in microglia through LPS- or IFN-gamma-mediated pathways. , 1996, Neuroreport.
[72] R. Romero,et al. Interleukin-6 concentrations in umbilical cord plasma are elevated in neonates with white matter lesions associated with periventricular leukomalacia. , 1996, American journal of obstetrics and gynecology.
[73] P. Kivisäkk,et al. Increased interleukin-6 mRNA expression in blood and cerebrospinal fluid mononuclear cells in multiple sclerosis , 1996, Journal of Neuroimmunology.
[74] P Riederer,et al. Interleukin-1 beta and interleukin-6 are elevated in the cerebrospinal fluid of Alzheimer's and de novo Parkinson's disease patients. , 1995, Neuroscience letters.
[75] P. Heinrich,et al. The soluble human IL-6 receptor. Mutational characterization of the proteolytic cleavage site. , 1994, Journal of immunology.
[76] G. Yancopoulos,et al. Association and activation of Jak-Tyk kinases by CNTF-LIF-OSM-IL-6 beta receptor components. , 1994, Science.
[77] A. Stalder,et al. Reactive gliosis as a consequence of interleukin-6 expression in the brain: studies in transgenic mice. , 1994, Developmental neuroscience.
[78] L. Mucke,et al. Neurologic disease induced in transgenic mice by cerebral overexpression of interleukin 6. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[79] J. R. Unnerstall,et al. The expression of CNTF message and immunoreactivity in the central and peripheral nervous system of the rat. , 1992, Brain research. Developmental brain research.
[80] H. Thoenen,et al. Regional distribution, developmental changes, and cellular localization of CNTF-mRNA and protein in the rat brain , 1991, The Journal of cell biology.
[81] U. Schreiter-Gasser,et al. Interleukin‐6 and α‐2‐macroglobulin indicate an acute‐phase state in Alzheimer's disease cortices , 1991, FEBS letters.
[82] W. Fiers,et al. Is amyloidogenesis during Alzheimer's disease due to an IL-1-/IL-6-mediated 'acute phase response' in the brain? , 1991, Immunology today.
[83] A. Reder,et al. Cytokine levels in the cerebrospinal fluid and serum of patients with multiple sclerosis , 1991, Journal of Neuroimmunology.
[84] A. Fontana,et al. Interleukin-6 is elevated in plasma in multiple sclerosis , 1991, Journal of Neuroimmunology.
[85] R. Zinkernagel,et al. On the cellular source and function of interleukin 6 produced in the central nervous system in viral diseases , 1989, European journal of immunology.